SDGR Schrodinger, Inc.

8-K Current Report

Filed: March 12, 2026

Health Care

Pharmaceutical Preparations

Schrodinger, Inc. (SDGR) 8-K current report filed with SEC EDGAR on March 12, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 5.02: Departure/Election of Directors or Officers

AI Filing Analysis
8-K

Item 5.02 · Departure/Election of Directors or Officers

• Therese Abrams designated principal accounting officer effective March 8, 2026; previously VP, Corporate Controller since July 2025
• Abrams is a CPA with 13+ years at Schrödinger across finance and revenue roles — internal promotion, no external search

+3 more insights

Other Schrodinger, Inc. 8-K Filings

8-K Feb 25, 2026

Get deeper insights on Schrodinger, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.